Skip to main content
SpringerLink
Log in

Oncogenic Transformation of Normal Enterocytes by Overexpression of Cyclin D1

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Cyclin D1 plays an important role in the multi-step process of gastrointestinal tumorigenesis. We hypothesize that normal enterocytes over-expressing Cyclin D1 will demonstrate a transformed phenotype. The nontumorigenic intestinal epithelial cell line, IEC-18, was transfected with the vector pMV7-CCND1, encoding Cyclin D1. Three clones, with cyclin D1 levels similar to those seen in colon cancer cell lines, were further evaluated in comparison to the vector control cells. They proliferated faster and demonstrated anchorage-independent growth in soft agar, higher saturation density, and higher plating efficiency. When injected into nude mice, tumors were generated after 6–8 weeks. On the other hand these cells were more sensitive to induction of apoptosis. There was no change in the level of β-catenin protein. In conclusion, Cyclin D1 can act as an oncogene in vitro and in vivo, when produced in immortalized normal intestinal epithelial cells. This model may be useful for understanding the role and interrelationships of Cyclin D1 in colorectal tumorigenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cole P, Sateren W: The evolving picture of cancer in America. JNCI 87:59-160, 1995

    Google Scholar 

  2. Parkin DM, Pisani P, Ferlay J: Global cancer statistics: CA-Cancer J Clin. 49:33-64, 1999

    Google Scholar 

  3. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990

    Google Scholar 

  4. Morson B. President's address: The polyp-cancer sequence in the large bowel. Proc R Soc Mes. 67:451-457, 1974

    Google Scholar 

  5. Pines J. Cyclins: wheels within wheels. Cell Growth Differ 2:305-310, 1991

    Google Scholar 

  6. Reed SI: The role of p34 kinases in the G1 to S phase transition. Annu Rev Cell Biol 8:529-561, 1992

    Google Scholar 

  7. Sherr CJ: Mammalian G1 cyclins. Cell 73:1059-1065, 1993

    Google Scholar 

  8. Hunter T, Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582, 1994

    Google Scholar 

  9. Sherr CJ: G1 phase progression: cycling on cue. Cell 79:551-555, 1994

    Google Scholar 

  10. Weinstein IB: Abnormalities in cell cycle regulation divided against itself. Helix 5:20-27, 1996

    Google Scholar 

  11. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A.: A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512-515, 2000

    Google Scholar 

  12. Xiong Y, Connolly T, Futcher B, Beach D: Human D-type cyclin. Cell 65:691-699, 1991

    Google Scholar 

  13. Lew DJ, Dulic V, Reed SI: Isolation of three novel human cyclins by rescue of G1 cyclin function in yeast. Cell 66:1197-1206, 1991

    Google Scholar 

  14. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713, 1991

    Google Scholar 

  15. Won KA, Xiong Y, Beach D, Gilman MZ: Growth regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci USA 89:9910-9914, 1992

    Google Scholar 

  16. Sewing A, Burger C, Brusselbach S, Schalk C, Lucibello FC, Muller R. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factor and suppressed by cyclic AMP. J Cell Sci 104:545-554, 1993

    Google Scholar 

  17. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ: Overexpression of mouse D type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559-1571, 1993

    Google Scholar 

  18. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene 9:707-718, 1994

    Google Scholar 

  19. Resnitzky D, Gossen M, Bujard H, Reed SI: Acceleration of the G1/S transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669-1679, 1994

    Google Scholar 

  20. Pardee AB: D types cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Science 246:603-608, 1989

    Google Scholar 

  21. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671, 1994

    Google Scholar 

  22. Hinds PW, Dowdy SF, NgEaton, E, et al: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709-713, 1994

    Google Scholar 

  23. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9:323-326, 1994

    Google Scholar 

  24. Marx J: How cells cycle toward cancer. Science 263:319-321, 1994

    Google Scholar 

  25. Nakagawa H, Wang TC, Zukerberg L, Odze R, Togawa K, May GH, Wilson J, Rustgi AK: The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene 14:1185-1190, 1997

    Google Scholar 

  26. Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R, Arnold A: Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107:1079-1080, 2001

    Google Scholar 

  27. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM: Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 13:2124-2130, 1994

    Google Scholar 

  28. Robles AI, Larcher F, Whalin RB, Murillas R, Richie E, Gimenez-Conti IB, Jorcano JL, Conti CJ: Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci USA, 93:7634-7638, 1996

    Google Scholar 

  29. Hunter T, Pines J. Cyclins and cancer. Cell 66:1071-1074, 1991

    Google Scholar 

  30. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439-444, 1991

    Google Scholar 

  31. Gaudray P, Szepetowski P, Escot C, Birnbaum D, Theillet C: DNA amplification at 11q13 in human cancer: from complexity to perplexity. Mutation Res. 276:317-328, 1992

    Google Scholar 

  32. Lammie GA, Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3:413-420, 1991

    Google Scholar 

  33. Motokura T, Arnold A: Cyclin D and oncogenesis. Curr Opin Genet Dev. 3:5-10, 1993

    Google Scholar 

  34. Arber N, Gammon MD, Hibshoosh H, Britton JA, Zhang Y, Schonberg JB, Roterdam H, Fabian I, Holt PR, Weinstein IB: Overexpression of cyclin D1 occurs in both saquamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach: Hum Pathol 30:1087-1092, 1999

    Google Scholar 

  35. Kornmann M, Arber N, Korc M: Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest 101:344-352, 1998

    Google Scholar 

  36. Kornmann M, Ishiwata T, Arber N, Beger HG, Korc M: Increased cyclin D1 expression in chronic pancreatitis. Pancreas 17:158-162, 1998

    Google Scholar 

  37. Arber N, Hibshoosh H, Yasui W, Neugut AI, Hibshoosh A, Yao Y, Sgambato A, Yamamoto H, Shapira I, Rosenman D, Fabian I, Weinstein IB, Tahara E, Holt PR: Abnormalities in the expression of cell cycle related proteins in tumors of the small bowel. Cancer Epidemiol Biomarkers Prev 12:1101-1105, 1999

    Google Scholar 

  38. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110:669-674, 1996

    Google Scholar 

  39. Bartkova J, Lukas J, Strauss M, Bartek J: The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a sub set of colorectal carcinomas. Int J Cancer 58:568-573, 1994

    Google Scholar 

  40. Sutter T, Doi S, Carnevale KA, Arber N, Weinstein IB: Expressions of cyclins D1 and E in human colon adenocarcinomas. J Med 28:285-309, 1997

    Google Scholar 

  41. Arber N, Lightdale C, Rotterdam H, Han KH, Sgambato A, Yap E, Ahsan H, Finegold J, Stevens PD, Green PH, Hibshoosh H, Neugut AI, Holt PR, Weinstein IB: Increased expression of the cyclin D1 gene in Barrett's esophagus. Cancer Epidemiol Biomark Prev 5:457-459, 1996

    Google Scholar 

  42. Zhou P, Jiang W, Zhang YJ, Kahn SM, Schieren I, Santella RM, Weinstein IB: Antisense of cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11:571-580, 1995

    Google Scholar 

  43. Arber N, Doki Y, Han EK, Sgambato A, Zhou P, Kim NH, Delohery T, Klein MG, Holt PR, Weinstein IB: Antisense to cyclin D1 inhibits the growth and tumorigenesis of human colon cancer cells. Cancer Res 57:1569-1574, 1997

    Google Scholar 

  44. Arber N, Strul H: Non-steroidal anti-inflammatory drugs and selective apoptotic antineoplastic drugs in the prevention of colorectal cancer: the role of super aspirins. Isr Med Assoc J 2:695-702, 2000

    Google Scholar 

  45. DuBois RN, Giardiello FM: Smalley WE. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am. 25:773-791, 1996.

    Google Scholar 

  46. Arber N: NSAIDs prevent colorectal cancer. Can J Gastroenterol 14:299-307, 2000

    Google Scholar 

  47. Thun MJ: NSAIDs use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Am 25:333-347, 1996

    Google Scholar 

  48. Quaroni A, Isselbacher KJ: Cytotoxic effects and metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in duodenal and ileal epithelial cell cultures. J Natl Cancer Inst 67:1353-1362, 1981

    Google Scholar 

  49. Arber N, Sutter T, Miyake M, Kahn SM, Venkatraj VS, Sobrino A, Warburton D, Holt PR, Weinstein IB: Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene 12:1903-1908, 1996

    Google Scholar 

  50. Kohno T, Yoshida S, Bessho M: Accelerated entry into S phase associated with up-regulation of cyclin D1 as a mechanisn for granulocyte colony-stimulating factor (G-CSF)-induced apoptosis of murine myeloid leukomia cells. Leuk Res 22:257-263, 1998

    Google Scholar 

  51. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91:2945-2949, 1994

    Google Scholar 

  52. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R, Weinstein IB: Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90:9026-9030, 1993

    Google Scholar 

  53. Kitahara K, Yasui W, Yokozaki H, Semba S, Hamamoto T, Hisatsugu T, Tahara E: Expression of cyclin D1, CDK4, and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoman cell lines. J Exp Ther Oncol. 1:7-12, 1996

    Google Scholar 

  54. Doki Y, Imoto M, Han EK, Sgambato A, Weinstein IB: Increased expression of the p27kip1 protein in human esophageal cancer cell lines that overexpress cyclin D1. Carcinogenesis 18:139-1148, 1997

    Google Scholar 

  55. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A.: The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 6:5522-5527, 1999

    Google Scholar 

  56. Opitz OG, Suliman Y, Hahn WC, Harada H, Blum HE, Rustgi AK: Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest 108:665-667, 2001

    Google Scholar 

Download references

Authors
  1. Diana Kazanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Itzhak Shapira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marjorie Pick
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olga Kolker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eliezer Liberman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Varda Deutsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Loudmilla Strier
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hadas Dvory-Sobol
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Talya Kunik
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Nadir Arber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kazanov, D., Shapira, I., Pick, M. et al. Oncogenic Transformation of Normal Enterocytes by Overexpression of Cyclin D1 . Dig Dis Sci 48, 1251–1261 (2003). https://doi.org/10.1023/A:1024138605802

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024138605802

Search

Navigation